Article

RA Patient Refusing Relief: Whose Right to Decide?

A patient with rheumatoid arthritis declines to take pain relievers. His wife says he needs them, but won't admit it. What should be done?

Stonington SD. A Piece of My Mind: Whose Autonomy?  JAMA (2014) 312:1099-1100. doi:10.1001/jama.2014.8273

This essay recounts the case of a 64-year-old man with rheumatoid arthritis who refused to take to take nonsteroidal anti-inflammatory drugs for pain, which the author had recommended adding to his methotrexate. The patient's wife said, “It is just part of his self-image to be tough and not treat his pain. But he needs treatment, whether he will say so or not.”

This brought to mind a similar experience while the author was doing anthropological fieldwork on end-of-life care in Northern Thailand. Medical staff and the son overruled the wishes of an elderly man with colorectal cancer, who underwent repeated resuscitation at his son's insistence but died before a planned surgery.

Had doctors violated his autonomy? The author, a Westerner, thought so. But a Thai nursing student argued that he was "thinking like a foreigner." The father's role, she said, is to say he is ready for whatever comes. The son's role is to try everything possible until the end. "They both do the right thing," she said, "and they both get merit.”

The essay goes on to discuss the relationship between patient autonomy and the role of the family and others, and how “merit” relates to the Asian concept of karma.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.